VIEWPOINTS PharmaShots Interview: GSK’s Tania Small Shares Insight on Target the Future ProgramBySenior EditorFebruary 23, 20220Comments
VIEWPOINTS PharmaShots Interview: Novartis’ Todd Fox Shares Insight on the US FDA’s Approval of Cosentyx for Enthesitis-Related Arthritis and Psoriatic ArthritisBySenior EditorFebruary 22, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Nikhil Lalwani of ANI Pharmaceuticals Shares Insight on Purified Cortrophin GelBySenior EditorFebruary 21, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in January 2022BySenior EditorFebruary 17, 20220Comments
VIEWPOINTS PharmaShots Interview: PolyPid’s Dikla Czaczkes Akselbrad Shares Insights on the P-III (SHIELD I) Trial of D-PLEX100BySenior EditorFebruary 16, 20220Comments
VIEWPOINTS PharmaShots Interview: 180 Life Sciences’ Dr. Jim Woody Shares Insight on Repurposing Anti-TNF to Meet Unmet Needs in Pain and InflammationBySenior EditorFebruary 15, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: John Meduri of Accelerate Diagnostics Shares Insight on Antimicrobial Resistance or AMRBySenior EditorFebruary 14, 20220Comments
VIEWPOINTS PharmaShots Interview: Myriad Genetics’ Todd Cohen Shares Insights on the Trends in Prostate Cancer and Precision MedicineBySenior EditorFebruary 9, 20220Comments
